The longitudinal study to test the sensitivity of the OCT based algorithm will tell whether this can used to determine changes in skin fibrosis over time and therefore used as an outcome measure in clinical trials and in clinical management. PubMed. 02/20/2013. (Also see: Skin Fibrosis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.